Drug
Biological Prohema CB
Biological Prohema CB: highest development phase Phase 1, developed by Fate Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Fate Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Biological: ProHema-CB NCT02354417 | Phase 1 | Hematologic Malignancies |
Latest
No recent events.
Follow Biological Prohema CB on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.